Airborne: Cold remedy claim

This lawsuit resulted in a class action settlement for monetary damages in the amount of $23.3 million for the affected consumers.

In 2007, CSPI's Litigation Department joined as counsel to a class-action lawsuit against Airborne, a dietary supplement that was marketed as a “natural cold remedy” that “provides 3 hours of protection against the common cold.” The label and other marketing also claimed clinical support.

Citing the lack of scientific evidence to substantiate this, and the potential harm in digesting excessive amounts of Vitamin A (contained in the supplement), the plaintiffs ultimately obtained a nationwide, class-action settlement for monetary damages for the class in the amount of $23.3 million.